丙丁酚抑制低密度脂蛋白氧化的作用
摘要
丙丁酚是临床应用的降脂药物,由于其结构中两个羟基取代的苯环而具有断链抗氧化剂活性,可干预抵密度脂蛋白的氧化修饰,抑制氧化型低密度脂蛋白形成,从而对动脉粥样硬化的防治有重要意义。
出处
《国外医学（老年医学分册）》
2000年第3期126-127,共2页
Foreign Medical Sciences(Geriatrics)
参考文献11
-
1Kuzyya M, Kuzuya F. Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med, 1993;14:67～77
-
2Bard JM, Urine S, Fruchart JC et al. Location of probucol in lipoproteins inferred from compositional analysis of lipoprotein particles. An in-vitro study. J Pharm Pharmacol, 1994;46:797～800
-
3Shinomiya M, Shirai K, Saito Y et al. Positive correlation between probucol in low density lipoprotein and LDL-lowering. Eur J Clin Pharmacol, 1993;45:343～346
-
4O' Leary VJ, Tilling L, Fleetwwod G et al. The resistance of low density lupoprotein to oxidation promoted by coper and its use as an index of antioxidant therapy. Atherosclerosis, 1996;119:169～173
-
5Sasahara M, Raines EW, Chait A et al. Inhibition of hypercholesterolemia induced atherosclerosis in the nonhuman promate by probucol. J Clin Invest, 1994;94:155～164
-
6Oshima R, Ikeda T, Watanabe K et al. Probucol treatment attenuates the aortic ahterosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis, 1998;137:13～22
-
7Braesen JH, Beisiegel U, Nitndort A. Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits. Virchows Archiv, 1995;426:179～188
-
8Dujovne CA, Harris WS, Gerond C et al. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins hyperlipoproteinemia. Am J Cardiol, 1994, 74:38～42
-
9Bittolo-bon G, Cazzolato G, Arogaro P. Probucol protects lowdensity lipoproteins form in vitro and in vivo oidation. Pharmacol Res, 1994;29:337～344
-
10Iliskovic NS, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycininduced cardiomyopathy in rats. Circulation, 1994;89:2829～2835
-
1郭永芳,宋达琳,何涛,康维强.氧化应激在代谢综合征致动脉粥样硬化中的作用[J].中国医药,2008,3(3):157-158. 被引量：1
-
2神经系统药物[J].国外科技资料目录（医药卫生）,1998(12):192-193.
-
3周华东,陈曼娥.动脉粥样硬化的发生与细胞间粘附分子[J].国外医学（老年医学分册）,1997,18(4):152-154. 被引量：9
-
4李栋.氨氯地平联合阿托伐他汀对高血压患者颈动脉内膜中层厚度的影响[J].疾病监测与控制,2016,10(1):69-70.
-
5许小勤.厄贝沙坦联合苯环酸氨氯地平治疗原发性高血压的临床效果分析[J].大家健康（学术版）,2014(12):160-161.
-
6吴文华,吴镇洲.茶多酚预防动脉粥样硬化的作用[J].国外医学（脑血管疾病分册）,2002,10(4):317-320. 被引量：5
-
7吴炜.罗格列酮对高脂血症家兔低密度脂蛋白氧化的影响[J].安徽医学,2012,33(9):1205-1207.
-
8杨科峰,蔡美琴.异黄酮对心血管作用的研究进展[J].上海第二医科大学学报,2005,25(5):532-534. 被引量：19
-
9程东庆,蔡琴,李毅,周芳美,沃兴德.姜黄素的微生物转化产物体外抗低密度脂蛋白氧化作用[J].中国动脉硬化杂志,2009,17(5):349-353.
-
10周春蕾,王达理,楼建英,王燕.辛伐他汀对人低密度脂蛋白氧化修饰影响的实验研究[J].中华今日医学杂志,2003,3(17):9-11.
